REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
13.62
-0.14 (-1.02%)
At close: Jan 16, 2026, 4:00 PM EST
13.70
+0.08 (0.59%)
After-hours: Jan 16, 2026, 7:47 PM EST
REGENXBIO Stock Forecast
Stock Price Forecast
The 9 analysts that cover REGENXBIO stock have a consensus rating of "Strong Buy" and an average price target of $30.78, which forecasts a 125.99% increase in the stock price over the next year. The lowest target is $12 and the highest is $52.
Price Target: $30.78 (+125.99%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 19, 2025.
Analyst Ratings
The average analyst rating for REGENXBIO stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 4 | 4 | 4 | 3 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 7 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $40 → $45 | Strong Buy | Maintains | $40 → $45 | +230.40% | Dec 19, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $16 → $20 | Buy | Maintains | $16 → $20 | +46.84% | Dec 15, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $52 | Strong Buy | Maintains | $52 | +281.79% | Nov 20, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $17 → $19 | Buy | Maintains | $17 → $19 | +39.50% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +149.63% | Oct 7, 2025 |
Financial Forecast
Revenue This Year
194.64M
from 83.33M
Increased by 133.58%
Revenue Next Year
282.38M
from 194.64M
Increased by 45.08%
EPS This Year
-3.09
from -4.59
EPS Next Year
-2.94
from -3.09
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 325.6M | 408.5M | ||||
| Avg | 194.6M | 282.4M | ||||
| Low | 156.9M | 143.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 290.8% | 109.8% | ||||
| Avg | 133.6% | 45.1% | ||||
| Low | 88.3% | -26.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.66 | -0.34 | ||||
| Avg | -3.09 | -2.94 | ||||
| Low | -4.03 | -5.12 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.